BDO Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

BDO Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.49K	Hold	12	–	–	﹤0.01%	876
2023 Q1	$1.76K	Sell	12 -17	-59%	-$2.52K	﹤0.01%	916
2022 Q4	$4.62K	Hold	29	–	–	﹤0.01%	773
2022 Q3	$4K	Hold	29	–	–	﹤0.01%	847
2022 Q2	$5K	Hold	29	–	–	﹤0.01%	781
2022 Q1	$5K	Hold	29	–	–	﹤0.01%	822
2021 Q4	$4K	Hold	29	–	–	﹤0.01%	866
2021 Q3	$4K	Sell	29 -50	-63%	-$7.55K	﹤0.01%	872
2021 Q2	$14K	Buy	79 +29	+58%	+$5.02K	﹤0.01%	698
2021 Q1	$8K	Buy	+50	New	+$8.23K	﹤0.01%	774
2020 Q2	–	Sell	-170	Closed	-$17K	–	731
2020 Q1	$17K	Buy	+170	New	+$22K	﹤0.01%	473
2019 Q2	–	Sell	-15	Closed	-$2K	–	651
2019 Q1	$2K	Hold	15	–	–	﹤0.01%	563
2018 Q4	$2K	Hold	15	–	–	﹤0.01%	496
2018 Q3	$3K	Hold	15	–	–	﹤0.01%	533
2018 Q2	$3K	Sell	15 -15	-50%	-$2.45K	﹤0.01%	548
2018 Q1	$5K	Hold	30	–	–	﹤0.01%	441
2017 Q4	$4K	Hold	30	–	–	﹤0.01%	388
2017 Q3	$4K	Hold	30	–	–	﹤0.01%	357
2017 Q2	$5K	Buy	+30	New	+$4.59K	﹤0.01%	428

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BDO Wealth Advisors's JAZZ Position: Q2 2023 in Review

BDO Wealth Advisors held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2023 at 12 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #876.

BDO Wealth Advisors first reported a position in JAZZ in Q2 2017 and has held it in 19 quarters since. The position peaked at $17K in Q1 2020. 471 funds tracked by Wall St. Rank hold JAZZ as of Q2 2023.

BDO Wealth Advisors held 12 shares of Jazz Pharmaceuticals worth $1.49K as of Q2 2023.
BDO Wealth Advisors left its Jazz Pharmaceuticals share count unchanged in Q2 2023.
Jazz Pharmaceuticals made up ﹤0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #876 holding.
BDO Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q2 2017 and has held it in 19 quarters since.
BDO Wealth Advisors's Jazz Pharmaceuticals position peaked at $17K in Q1 2020.
471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.